PMID: 2503384Jul 1, 1989Paper

Effect of artificial electron acceptors on the cytotoxicity of mitomycin C and doxorubicin in human lung tumor cells

European Journal of Cancer & Clinical Oncology
H G KeizerH Joenje

Abstract

The cytotoxicities of mitomycin C (MMC) and doxorubicin (DOX) have been proposed to depend on intracellular reduction by reduced flavoproteins. We investigated whether MMC- and DOX-induced cytotoxicity could be inhibited by competing for electrons from reduced flavoproteins by the artificial electron acceptors phenazine methosulfate (PMS), menadione (MEN) and methylene blue (MB). In intact SW-1573 human lung tumor cells these compounds proved to be excellent electron acceptors, as judged from their capacity to induce high levels of cyanide-resistant respiration. In addition, PMS, MEN and MB were found to decrease the cytotoxicity of MMC, by 90, 63 and 29%, respectively, at concentrations that were themselves completely nontoxic. In contrast, DOX cytotoxicity was not detectably affected. These results suggest that in SW-1573 cells flavoprotein-mediated bioreduction is required for the cytotoxic effect of MMC, but not for that of DOX.

References

Nov 1, 1979·Analytical Biochemistry·B M Jørgensen, H N Rasmussen
Dec 1, 1985·Archives of Biochemistry and Biophysics·M W SutherlandH J Forman
Jan 31, 1972·Biochemical and Biophysical Research Communications·M NishikimiK Yagi
May 1, 1983·Archives of Biochemistry and Biophysics·P L GutiérrezN R Bachur
Feb 28, 1984·Biochemistry·H EliotC Myers
May 15, 1982·Biochemical Pharmacology·W E Ross, M C Smith

❮ Previous
Next ❯

Citations

Jan 1, 1995·Cancer Chemotherapy and Pharmacology·K A MargolinJ H Doroshow
Jan 1, 1995·Investigational New Drugs·M TetefJ H Doroshow
Jan 1, 1995·Journal of Cancer Research and Clinical Oncology·M TetefS Shibata
May 4, 2005·Investigational New Drugs·Dean LimJames H Doroshow
Jun 1, 1992·American Journal of Medical Genetics·L P ten Kate

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.